Immuron Ltd
IMM-124E
gut health during deployment and travel
Date
TBD
Phase 2 readout · Date TBD estimated
What's at stake
Phase 2 trial results for IMM-124E in gut health during deployment and travel are due Date TBD. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 6-K
verified 13h ago
“The primary endpoint did not reach statistical significance.”